Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice

This study has been completed.

Sponsor:

Collaborators:

Reckitt and Colman

Information provided by:

Department of Veterans Affairs

ClinicalTrials.gov Identifier:

NCT00007527

First received: December 29, 2000

Last updated: January 20, 2009

Last verified: February 2003

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	January 2002
Estimated Primary Completion Date:	No date given